Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q44696111

about

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Statins for non-alcoholic steatohepatitis Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis Nonalcoholic fatty liver disease Treatment of non-alcoholic fatty liver disease A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes Statins in liver disease: a molehill, an iceberg, or neither?Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline.Treatment options for nonalcoholic Fatty liver disease Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Current status of therapy in nonalcoholic Fatty liver disease.Surgical treatment of nonalcoholic fatty liver disease in severely obese patients Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease Treatment of non-alcoholic fatty liver disease.Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.Pathogenesis and management issues for non-alcoholic fatty liver disease Way back for fructose and liver metabolism: bench side to molecular insights.Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Pharmacological treatment of non-alcoholic steatohepatitis: the current evidence.Dyslipidemia in patients with nonalcoholic fatty liver disease.Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Review article: diagnosis and treatment of non-alcoholic fatty liver disease.Current treatment of non-alcoholic fatty liver disease.Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk.Non-alcoholic fatty liver disease from pathogenesis to management: an update.Nonalcoholic fatty liver disease in children living in the obeseogenic society.Nonalcoholic fatty liver disease: a review and update.Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease.Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review.Nonalcoholic fatty liver disease: current issues and novel treatment approaches.Pharmacologic therapy for nonalcoholic fatty liver disease in adults.Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition.Pharmacotherapy for Nonalcoholic Fatty Liver Disease.Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study.Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease.

P2860

Q24201595-47D7CEFD-DE84-4EBE-BADF-29E39F283EC4 Q24234628-C20814C0-D8DB-4EED-8521-09E8F36886DC Q24243149-35887F9E-6746-4E77-A9C8-C4262F9E8C60 Q24555779-35777A1F-EBCE-48E0-94D1-6E78AC00B64F Q24655572-E5A41AEB-79A0-4B39-9454-68DA1F727F2A Q26752487-88D07F8A-DDFA-42AE-AB9C-E2CFEDE59032 Q26825269-468765E6-59F8-48D0-969C-DBA7B0B01676 Q26853571-993BF32A-4570-46DC-8DCC-C635DFFE9170 Q30446668-99977894-2B0A-4ABB-AF76-0DF5D6BC9DD3 Q33723738-B676A514-F2CF-4D9B-998B-6A68F296CC10 Q34156317-7FD03696-FD62-49EA-8190-14B48EBCDB15 Q34168532-949FED9F-E0F4-40B4-ADB5-FE7F06398786 Q34408961-C28FD758-E9B4-4902-A46D-8D156590D20F Q34446294-F8EEBED5-8300-4CCA-9457-7B69B2D71814 Q34449857-59A93371-1758-45D0-AC6A-C5004D709D2C Q34592654-B5101929-E001-49FF-A3C9-0E2E60866E45 Q35716357-D1574A8F-BC72-4583-94AD-18C42D486293 Q36179902-9231513C-0F55-4D9D-88FA-9751003534E8 Q36450525-6E665507-7F30-4440-B9C4-D90FC011219A Q36470320-D9885006-501E-426E-A104-4A56B7A13533 Q36747250-810CD140-43A6-4005-9D77-861DF4F3B5EF Q36845703-DFC6CD83-7D3D-4B89-AAA0-1FA452BAD199 Q37137987-9B1A6D2A-524A-4E11-BE25-AA999406B459 Q37183154-2EEC24F1-DEA5-4B7B-9CE6-1AF8E14512FF Q37194846-CF2E92BF-C245-4CA5-AE5B-A16004040BBE Q37530973-E25F1DFA-7573-4FF3-9CBB-6A07CF4DA4A4 Q37618979-6A597275-5763-47AA-ACE1-F060091C365F Q37632281-0C0D5F5D-E0A4-4B84-9052-16E465E53EA3 Q37681360-9EE430B7-37FA-4EC3-92B4-A04FBBB3B5B2 Q37721436-7D33EEBC-E634-49A6-8311-4FD028CCA96A Q37768230-8F993AE9-B05A-4B5F-8D9D-E452FA9C6E2D Q37993779-BB51C3B8-7848-472B-B4AC-F3DE8389E7F0 Q38074826-D26E1305-9220-4018-8746-5DB6008B48B8 Q38074898-008125F4-5FEE-41AD-855A-7E8968463EE7 Q38077516-2442AA72-7709-42E0-A62A-91495A1BFB92 Q38195808-33C4FC9B-7FA0-4891-9BE5-DC7AD679C925 Q38588344-8931D630-FD0E-4AC0-A653-698F1815A187 Q38782562-75D54258-C0BE-41BF-8BAF-1184C5F484F5 Q39617773-F57B90C3-86EC-4749-BFC5-065AD03FC319 Q39646058-F2F70FFC-0313-4E02-8F87-D99630B1EADA

P2860

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q44696111

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@en

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@nl

type

label

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@en

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@nl

prefLabel

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@en

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@nl

P1433

Q44696111-21711E6E-2320-444A-AADC-A2C808F353FD

P1476

Q44696111-C40F2C5F-5BB5-48FB-ABF8-364C022ECC27

P2093

Q44696111-00A94568-E7A6-4CF2-B6E6-953330180DF8

Q44696111-1DB94F05-69DF-4B03-A300-5628E91E9E4D

Q44696111-2045201E-E57E-4745-BA11-8A3A9B24CFE3

Q44696111-3FB29A51-FCC5-4CF8-B27F-BD569D8DC8C9

Q44696111-4D2C96A2-F757-4591-9459-E5BFC879B518

Q44696111-501061DB-28C8-4034-BDD1-40555FAFCD79

Q44696111-65641FC9-C430-4F80-A327-7128CF79810B

Q44696111-68DF5831-7A99-4D53-935B-116307D6E343

Q44696111-73E871F5-29F8-4C52-A230-597D6AADD175

P304

Q44696111-3FD6A53C-7CF0-447F-B289-684DE6B3A765

P31

Q44696111-6CA0275E-46D8-44DF-820F-14FB2A7E6BAE

P356

Q44696111-8897C4D1-B44D-4A2A-A5B6-621176F86B57

P407

Q44696111-846D187D-3FCC-4422-8CC8-BE682B43FD52

P433

Q44696111-7B87C966-3AD9-4D06-BF6D-ABC8723C7F66

P478

Q44696111-77748966-448E-4052-9E5B-4CEAF23B4367

P577

Q44696111-0A60C980-5A78-40C3-A705-ABCB27FE8DFF

P5875

Q44696111-773F0AFB-2AA5-4C23-A661-8CFFF7BC13B2

P698

Q44696111-8AF37366-50C2-42E5-9C6B-0634D0B2D30E

P921

Q44696111-5ED4358D-2C73-4584-B409-CE17076B161D

P356

P1433

Canadian Journal of Gastroenterology & Hepatology

P1476

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.

@en

P2093

Enver Dolar

http://www.w3.org/2001/XMLSchema#string

Faruk Memik

http://www.w3.org/2001/XMLSchema#string

Gursel Savci

http://www.w3.org/2001/XMLSchema#string

Macit Gulten

http://www.w3.org/2001/XMLSchema#string

Murat Kiyici

http://www.w3.org/2001/XMLSchema#string

Omer Yerci

http://www.w3.org/2001/XMLSchema#string

Saduman Balaban Adim

http://www.w3.org/2001/XMLSchema#string

Selim Giray Nak

http://www.w3.org/2001/XMLSchema#string

Selim Gurel

http://www.w3.org/2001/XMLSchema#string

P304

713-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2003/857869

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8956772

http://www.w3.org/2001/XMLSchema#string

P698

14679419

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis